These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 30384963

  • 1. [Management of renal failure in old patients undergoing percutaneous cardiac interventions].
    Aubry P, Demian H.
    Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):466-473. PubMed ID: 30384963
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR, Rahim S, Etherington K, Rokoss ML, Natarajan MK, Velianou JL, Brons S, Mehta SR, CAPTAIN Investigators.
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [Abstract] [Full Text] [Related]

  • 5. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Shehata M, Hamza M.
    Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optical coherence tomography-guided percutaneous coronary intervention in a patient with chronic kidney disease using zero contrast administration.
    Rivero F, Antuña P, Cuesta J, García-Guimaraes M, Bastante T, Alfonso F.
    Coron Artery Dis; 2019 Mar; 30(2):156-157. PubMed ID: 30531255
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Lee SH, Gwon HC.
    Am J Cardiol; 2014 Dec 15; 114(12):1830-5. PubMed ID: 25438909
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter aortic valve implantation of the direct flow medical aortic valve with minimal or no contrast.
    Latib A, Maisano F, Colombo A, Klugmann S, Low R, Smith T, Davidson C, Harreld JH, Bruschi G, DeMarco F.
    Cardiovasc Revasc Med; 2014 Jun 15; 15(4):252-7. PubMed ID: 24721585
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L, Hejazi SF, Sadeghi MS, Jang SA.
    Cardiol J; 2017 Jun 15; 24(5):502-507. PubMed ID: 28281738
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.